Cart
sales@molnova.com
Sodium Demethylcantharidate
CAS No. 13114-29-9
Sodium Demethylcantharidate( —— )
Catalog No. M11253 CAS No. 13114-29-9
Extracted from Mylabris phqlarata pallas;Store the product in sealed, cool and dry condition.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 45 | In Stock |
|
| 25MG | 71 | In Stock |
|
| 50MG | 107 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSodium Demethylcantharidate
-
NoteResearch use only, not for human use.
-
Brief DescriptionExtracted from Mylabris phqlarata pallas;Store the product in sealed, cool and dry condition.
-
DescriptionExtracted from Mylabris phqlarata pallas;Store the product in sealed, cool and dry condition.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number13114-29-9
-
Formula Weight230.14
-
Molecular FormulaC8H8Na2O5
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESC1CC2C(C(C1O2)C(=O)[O-])C(=O)[O-].[Na+].[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Goldstein P, Leshem M. Appetite. 2014 Aug;79:83-90
molnova catalog
related products
-
MRT-2359
MRT-2359 is a potent and orally available GSPT1 reducer with antitumour activity.MRT-2359 inhibits the growth of drug-resistant non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells.MRT-2359 exhibits preferential activity in MYC-driven cell lines.
-
Vazegepant HCl
Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
-
ML204
ML204 is a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels.
